TY - JOUR
T1 - Imaging criteria for assessing tumour response
T2 - RECIST, mRECIST, Cheson
AU - Fournier, L.
AU - Ammari, S.
AU - Thiam, R.
AU - Cuénod, C. A.
PY - 2014/1/1
Y1 - 2014/1/1
N2 - Most methods define a limited number of "target" lesions to be measured and other "non-target" lesions to be evaluated qualitatively. RECIST criteria are the most widely used although other criteria have been proposed that are derived from them based on size alone, or size and attenuation. Modified RECIST (mRECIST) criteria only concern hepatocellular carcinoma and only take into account the viable portion (enhanced after injection during the arterial phase). Cheson criteria are more complex as target lesions are defined differently depending on the organ (lymph nodes, liver or spleen, other organs), and involve both CT and PET scans, as well as the clinical examination and bone marrow biopsy.
AB - Most methods define a limited number of "target" lesions to be measured and other "non-target" lesions to be evaluated qualitatively. RECIST criteria are the most widely used although other criteria have been proposed that are derived from them based on size alone, or size and attenuation. Modified RECIST (mRECIST) criteria only concern hepatocellular carcinoma and only take into account the viable portion (enhanced after injection during the arterial phase). Cheson criteria are more complex as target lesions are defined differently depending on the organ (lymph nodes, liver or spleen, other organs), and involve both CT and PET scans, as well as the clinical examination and bone marrow biopsy.
KW - CT
KW - Hepatocellular carcinoma
KW - MRI
KW - RECIST criteria
KW - Tumour
UR - http://www.scopus.com/inward/record.url?scp=84906936262&partnerID=8YFLogxK
U2 - 10.1016/j.diii.2014.05.002
DO - 10.1016/j.diii.2014.05.002
M3 - Short survey
C2 - 24951349
AN - SCOPUS:84906936262
SN - 2211-5684
VL - 95
SP - 689
EP - 703
JO - Diagnostic and Interventional Imaging
JF - Diagnostic and Interventional Imaging
IS - 7-8
ER -